$LGND Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in LIGAND PHARMACEUTICALS INC.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in LIGAND PHARMACEUTICALS INC. Get notifications about new insider transactions in LIGAND PHARMACEUTICALS INC for free.

Page: < prev 1 2 3 4 5 6 7 8 ... 15 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Aug 10 2017	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Option Exercise	M	9.97	850	8,475	43,085
Aug 10 2017	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Option Exercise	M	9.97	6,100	60,817	43,935
Aug 10 2017	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Buy	M	9.97	850	8,475	95,770	94.9 K to 95.8 K (+0.90 %)
Aug 10 2017	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Sell	S	127.51	6,100	777,824	94,920	101 K to 94.9 K (-6.04 %)
Aug 10 2017	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Buy	M	9.97	6,100	60,817	101,020	94.9 K to 101 K (+6.43 %)
Aug 10 2017	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Sell	S	126.96	18,625	2,364,671	24,423	43 K to 24.4 K (-43.27 %)
Aug 10 2017	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Option Exercise	M	21.00	5,483	115,143	5,000
Aug 10 2017	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Sell	S	125.00	5,483	685,375	139,171	144.7 K to 139.2 K (-3.79 %)
Aug 10 2017	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Buy	M	21.00	5,483	115,143	144,654	139.2 K to 144.7 K (+3.94 %)
Aug 08 2017	LGND	LIGAND PHARMACEUTI ...	Korenberg Matthew E	VP, Finance and CFO	Payment of Exercise	F	122.06	609	74,335	14,706	15.3 K to 14.7 K (-3.98 %)
Jul 05 2017	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Buy	J	87.13	243	21,171	43,048	42.8 K to 43 K (+0.57 %)
Jul 05 2017	LGND	LIGAND PHARMACEUTI ...	Korenberg Matthew E	VP, Finance and CFO	Buy	J	87.13	243	21,171	15,315	15.1 K to 15.3 K (+1.61 %)
Jun 23 2017	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Option Exercise	M	21.00	4,666	97,986	0
Jun 23 2017	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Option Exercise	A	21.00	4,666	97,986	4,666
Jun 23 2017	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Sell	S	120.00	4,666	559,920	139,171	143.8 K to 139.2 K (-3.24 %)
Jun 23 2017	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Buy	M	21.00	4,666	97,986	143,837	139.2 K to 143.8 K (+3.35 %)
Jun 09 2017	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Option Exercise	M	21.00	12,000	252,000	10,483
Jun 09 2017	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Sell	S	114.87	12,000	1,378,440	139,171	151.2 K to 139.2 K (-7.94 %)
Jun 09 2017	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Buy	M	21.00	12,000	252,000	151,171	139.2 K to 151.2 K (+8.62 %)
May 30 2017	LGND	LIGAND PHARMACEUTI ...	Sabba Stephen L	Director	Option Exercise	A	113.50	2,456	278,756	2,456
May 30 2017	LGND	LIGAND PHARMACEUTI ...	Sabba Stephen L	Director	Grant	A	0.00	666	0	27,910	27.2 K to 27.9 K (+2.44 %)
May 26 2017	LGND	LIGAND PHARMACEUTI ...	Davis Todd C	Director	Option Exercise	A	113.50	2,456	278,756	2,456
May 26 2017	LGND	LIGAND PHARMACEUTI ...	Davis Todd C	Director	Grant	A	0.00	666	0	70,807	70.1 K to 70.8 K (+0.95 %)
May 26 2017	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Option Exercise	A	113.50	2,456	278,756	2,456
May 26 2017	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Grant	A	0.00	666	0	59,625	59 K to 59.6 K (+1.13 %)
May 26 2017	LGND	LIGAND PHARMACEUTI ...	Patel Sunil	Director	Option Exercise	A	113.50	2,456	278,756	2,456
May 26 2017	LGND	LIGAND PHARMACEUTI ...	Patel Sunil	Director	Grant	A	0.00	666	0	39,313	38.6 K to 39.3 K (+1.72 %)
May 26 2017	LGND	LIGAND PHARMACEUTI ...	LAMATTINA JOHN L	Director	Option Exercise	A	113.50	2,456	278,756	2,456
May 26 2017	LGND	LIGAND PHARMACEUTI ...	LAMATTINA JOHN L	Director	Grant	A	0.00	666	0	20,956	20.3 K to 21 K (+3.28 %)
May 26 2017	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Option Exercise	A	113.50	2,456	278,756	2,456
May 26 2017	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Grant	A	0.00	666	0	40,649	40 K to 40.6 K (+1.67 %)
May 15 2017	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Option Exercise	M	9.97	2,200	21,934	50,035
May 15 2017	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Option Exercise	M	9.97	5,621	56,041	52,235
May 15 2017	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Buy	M	9.97	2,200	21,934	94,920	92.7 K to 94.9 K (+2.37 %)
May 15 2017	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Sell	S	112.20	5,621	630,650	92,720	98.3 K to 92.7 K (-5.72 %)
May 15 2017	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Buy	M	9.97	5,621	56,041	98,341	92.7 K to 98.3 K (+6.06 %)
May 12 2017	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Sell	S	111.87	14,582	1,631,334	116,651	131.2 K to 116.7 K (-11.11 %)
May 12 2017	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Sell	S	110.04	22,665	2,494,025	131,233	153.9 K to 131.2 K (-14.73 %)
Mar 21 2017	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Sell	S	109.10	4,000	436,400	139,171	143.2 K to 139.2 K (-2.79 %)
Mar 10 2017	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Option Exercise	M	10.05	15,675	157,534	0
Mar 10 2017	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Payment of Exercise	F	106.92	1,473	157,493	143,171	144.6 K to 143.2 K (-1.02 %)
Mar 10 2017	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Buy	M	10.05	15,675	157,534	144,644	129 K to 144.6 K (+12.15 %)
Mar 10 2017	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Sell	S	107.06	4,000	428,240	128,969	133 K to 129 K (-3.01 %)
Mar 03 2017	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Option Exercise	M	9.97	2,000	19,940	57,856
Mar 03 2017	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Option Exercise	M	9.97	6,879	68,584	59,856
Mar 03 2017	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Buy	M	9.97	2,000	19,940	92,720	90.7 K to 92.7 K (+2.20 %)
Mar 03 2017	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Sell	S	103.39	6,879	711,214	90,720	97.6 K to 90.7 K (-7.05 %)
Mar 03 2017	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Buy	M	9.97	6,879	68,584	97,599	90.7 K to 97.6 K (+7.58 %)
Feb 28 2017	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Sell	S	107.58	7,000	753,060	153,898	160.9 K to 153.9 K (-4.35 %)
Feb 28 2017	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Sell	S	106.00	25,000	2,650,000	160,898	185.9 K to 160.9 K (-13.45 %)
Feb 28 2017	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Option Exercise	A	100.38	9,643	967,964	9,643
Feb 28 2017	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Grant	A	0.00	2,259	0	42,805	40.5 K to 42.8 K (+5.57 %)
Feb 28 2017	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Grant	A	0.00	2,619	0	40,546	37.9 K to 40.5 K (+6.91 %)
Feb 28 2017	LGND	LIGAND PHARMACEUTI ...	Korenberg Matthew E	VP, Finance and CFO	Option Exercise	A	100.38	15,225	1,528,286	15,225
Feb 28 2017	LGND	LIGAND PHARMACEUTI ...	Korenberg Matthew E	VP, Finance and CFO	Grant	A	0.00	3,567	0	15,072	11.5 K to 15.1 K (+31.00 %)
Feb 28 2017	LGND	LIGAND PHARMACEUTI ...	Korenberg Matthew E	VP, Finance and CFO	Payment of Exercise	F	100.38	1,051	105,499	11,505	12.6 K to 11.5 K (-8.37 %)
Feb 28 2017	LGND	LIGAND PHARMACEUTI ...	Korenberg Matthew E	VP, Finance and CFO	Grant	A	0.00	3,450	0	12,556	9.1 K to 12.6 K (+37.89 %)
Feb 28 2017	LGND	LIGAND PHARMACEUTI ...	Korenberg Matthew E	VP, Finance and CFO	Payment of Exercise	F	104.28	391	40,773	9,106	9.5 K to 9.1 K (-4.12 %)
Feb 28 2017	LGND	LIGAND PHARMACEUTI ...	Korenberg Matthew E	VP, Finance and CFO	Payment of Exercise	F	123.30	609	75,090	9,457	10.1 K to 9.5 K (-6.05 %)
Feb 28 2017	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Option Exercise	A	100.38	25,376	2,547,243	25,376
Feb 28 2017	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Grant	A	0.00	7,544	0	90,720	83.2 K to 90.7 K (+9.07 %)
Feb 28 2017	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Payment of Exercise	F	100.38	2,733	274,339	83,176	85.9 K to 83.2 K (-3.18 %)
Feb 28 2017	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Grant	A	0.00	5,239	0	85,909	80.7 K to 85.9 K (+6.49 %)
Feb 28 2017	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Payment of Exercise	F	104.28	725	75,603	80,670	81.4 K to 80.7 K (-0.89 %)
Feb 28 2017	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Payment of Exercise	F	104.28	1,642	171,228	81,395	83 K to 81.4 K (-1.98 %)
Feb 28 2017	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Option Exercise	A	100.38	43,646	4,381,185	43,646
Feb 28 2017	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Grant	A	0.00	10,224	0	132,969	122.7 K to 133 K (+8.33 %)
Feb 28 2017	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Payment of Exercise	F	100.38	4,783	480,118	122,745	127.5 K to 122.7 K (-3.75 %)
Feb 28 2017	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Grant	A	0.00	9,168	0	127,528	118.4 K to 127.5 K (+7.75 %)
Feb 28 2017	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Payment of Exercise	F	104.28	2,019	210,541	118,360	120.4 K to 118.4 K (-1.68 %)
Feb 28 2017	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Payment of Exercise	F	104.28	2,285	238,280	120,379	122.7 K to 120.4 K (-1.86 %)
Jan 03 2017	LGND	LIGAND PHARMACEUTI ...	Korenberg Matthew E	VP, Finance and CFO	Buy	J	86.37	40	3,455	10,106	10.1 K to 10.1 K (+0.40 %)
Dec 29 2016	LGND	LIGAND PHARMACEUTI ...	Davis Todd C	Director	Gift	G	0.00	48	0	70,141	70.2 K to 70.1 K (-0.07 %)
Nov 25 2016	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Sell	S	106.96	3,478	372,007	185,898	189.4 K to 185.9 K (-1.84 %)
Nov 25 2016	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Sell	S	107.40	15,001	1,611,065	189,376	204.4 K to 189.4 K (-7.34 %)
Nov 18 2016	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Sell	S	105.00	5,000	525,000	204,377	209.4 K to 204.4 K (-2.39 %)
Nov 18 2016	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Sell	S	106.33	1,330	141,419	209,377	210.7 K to 209.4 K (-0.63 %)
Nov 01 2016	LGND	LIGAND PHARMACEUTI ...	Davis Todd C	Director	Option Exercise	M	67.53	3,312	223,659	0
Nov 01 2016	LGND	LIGAND PHARMACEUTI ...	Davis Todd C	Director	Option Exercise	M	53.34	3,333	177,782	0
Nov 01 2016	LGND	LIGAND PHARMACEUTI ...	Davis Todd C	Director	Option Exercise	M	32.30	7,335	236,921	0
Nov 01 2016	LGND	LIGAND PHARMACEUTI ...	Davis Todd C	Director	Buy	M	67.53	3,312	223,659	70,189	66.9 K to 70.2 K (+4.95 %)
Nov 01 2016	LGND	LIGAND PHARMACEUTI ...	Davis Todd C	Director	Buy	M	32.30	7,335	236,921	66,877	59.5 K to 66.9 K (+12.32 %)
Nov 01 2016	LGND	LIGAND PHARMACEUTI ...	Davis Todd C	Director	Buy	M	53.34	3,333	177,782	59,542	56.2 K to 59.5 K (+5.93 %)
Sep 23 2016	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Sell	S	117.34	3,000	352,020	122,664	125.7 K to 122.7 K (-2.39 %)
Sep 09 2016	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Sell	S	115.00	1,000	115,000	39,983	41 K to 40 K (-2.44 %)
Sep 06 2016	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Sell	S	106.87	200	21,373	39,317	39.5 K to 39.3 K (-0.51 %)
Sep 06 2016	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Sell	S	105.82	866	91,643	39,517	40.4 K to 39.5 K (-2.14 %)
Sep 06 2016	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Sell	S	104.66	400	41,863	40,383	40.8 K to 40.4 K (-0.98 %)
Sep 06 2016	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Sell	S	103.59	200	20,718	40,783	41 K to 40.8 K (-0.49 %)
Aug 09 2016	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Option Exercise	M	21.92	4,295	94,146	469
Aug 09 2016	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Option Exercise	M	74.42	12,084	899,291	7,916
Aug 09 2016	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Option Exercise	M	56.26	5,688	320,007	10,369
Aug 09 2016	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Option Exercise	M	42.90	4,947	212,226	0
Aug 09 2016	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Option Exercise	M	40.86	3,333	136,186	0
Aug 09 2016	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Buy	M	40.86	3,333	136,186	37,927	34.6 K to 37.9 K (+9.63 %)
Aug 09 2016	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Buy	M	42.90	4,947	212,226	34,594	29.6 K to 34.6 K (+16.69 %)
Aug 09 2016	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Sell	S	123.16	12,084	1,488,265	29,647	41.7 K to 29.6 K (-28.96 %)
Aug 09 2016	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Buy	M	74.42	12,084	899,291	41,731	29.6 K to 41.7 K (+40.76 %)
Aug 09 2016	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Sell	S	123.16	5,688	700,534	29,647	35.3 K to 29.6 K (-16.10 %)
Aug 09 2016	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Buy	M	56.26	5,688	320,007	35,335	29.6 K to 35.3 K (+19.19 %)
Aug 09 2016	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Sell	S	123.16	4,295	528,972	29,647	33.9 K to 29.6 K (-12.65 %)
Aug 09 2016	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Buy	M	21.92	4,295	94,146	33,942	29.6 K to 33.9 K (+14.49 %)
Aug 09 2016	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Option Exercise	M	9.97	4,125	41,126	66,735
Aug 09 2016	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Option Exercise	M	9.97	12,500	124,625	70,860
Aug 09 2016	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Buy	M	9.97	4,125	41,126	83,037	78.9 K to 83 K (+5.23 %)
Aug 09 2016	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Sell	S	122.14	12,500	1,526,750	78,912	91.4 K to 78.9 K (-13.67 %)
Aug 09 2016	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Buy	M	9.97	12,500	124,625	91,412	78.9 K to 91.4 K (+15.84 %)
Aug 02 2016	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Sell	S	139.51	100	13,951	40,983	41.1 K to 41 K (-0.24 %)
Aug 02 2016	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Sell	S	138.31	200	27,662	41,083	41.3 K to 41.1 K (-0.48 %)
Aug 02 2016	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Sell	S	137.60	500	68,800	41,283	41.8 K to 41.3 K (-1.20 %)
Aug 02 2016	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Sell	S	135.78	200	27,156	41,783	42 K to 41.8 K (-0.48 %)
Jul 05 2016	LGND	LIGAND PHARMACEUTI ...	Korenberg Matthew E	VP, Finance and CFO	Buy	J	87.10	196	17,072	10,066	9.9 K to 10.1 K (+1.99 %)
Jul 05 2016	LGND	LIGAND PHARMACEUTI ...	Herman Melanie J	Director of Account ...	Buy	J	87.10	157	13,675	3,454	3.3 K to 3.5 K (+4.76 %)
Jul 05 2016	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Sell	S	122.23	100	12,223	41,983	42.1 K to 42 K (-0.24 %)
Jul 05 2016	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Sell	S	121.54	800	97,232	42,083	42.9 K to 42.1 K (-1.87 %)
Jul 05 2016	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Sell	S	119.47	100	11,947	42,883	43 K to 42.9 K (-0.23 %)
Jun 03 2016	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Sell	S	119.48	100	11,948	42,983	43.1 K to 43 K (-0.23 %)
Jun 03 2016	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Sell	S	117.19	900	105,471	43,083	44 K to 43.1 K (-2.05 %)
Jun 03 2016	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Gift	G	0.00	350	0	43,361	43.7 K to 43.4 K (-0.80 %)
May 25 2016	LGND	LIGAND PHARMACEUTI ...	Sabba Stephen L	Director	Option Exercise	A	119.30	2,329	277,850	2,329
May 25 2016	LGND	LIGAND PHARMACEUTI ...	Sabba Stephen L	Director	Grant	A	0.00	622	0	27,244	26.6 K to 27.2 K (+2.34 %)
May 25 2016	LGND	LIGAND PHARMACEUTI ...	Patel Sunil	Director	Option Exercise	A	119.30	2,329	277,850	2,329
May 25 2016	LGND	LIGAND PHARMACEUTI ...	Patel Sunil	Director	Grant	A	0.00	622	0	38,647	38 K to 38.6 K (+1.64 %)
May 25 2016	LGND	LIGAND PHARMACEUTI ...	LAMATTINA JOHN L	Director	Option Exercise	A	119.30	2,329	277,850	2,329
May 25 2016	LGND	LIGAND PHARMACEUTI ...	LAMATTINA JOHN L	Director	Grant	A	0.00	188	0	20,290	20.1 K to 20.3 K (+0.94 %)
May 25 2016	LGND	LIGAND PHARMACEUTI ...	LAMATTINA JOHN L	Director	Grant	A	0.00	622	0	20,102	19.5 K to 20.1 K (+3.19 %)
May 25 2016	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Option Exercise	A	119.30	2,329	277,850	2,329
May 25 2016	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Grant	A	0.00	622	0	44,333	43.7 K to 44.3 K (+1.42 %)
May 25 2016	LGND	LIGAND PHARMACEUTI ...	Davis Todd C	Director	Option Exercise	A	119.30	2,329	277,850	2,329
May 25 2016	LGND	LIGAND PHARMACEUTI ...	Davis Todd C	Director	Grant	A	0.00	188	0	56,209	56 K to 56.2 K (+0.34 %)
May 25 2016	LGND	LIGAND PHARMACEUTI ...	Davis Todd C	Director	Grant	A	0.00	622	0	56,021	55.4 K to 56 K (+1.12 %)
May 25 2016	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Option Exercise	A	119.30	2,329	277,850	2,329
May 25 2016	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Grant	A	0.00	622	0	58,959	58.3 K to 59 K (+1.07 %)
May 19 2016	LGND	LIGAND PHARMACEUTI ...	Herman Melanie J	Director of Account ...	Sell	S	120.50	334	40,247	3,297	3.6 K to 3.3 K (-9.20 %)
May 09 2016	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Sell	S	118.52	15,000	1,777,833	210,707	225.7 K to 210.7 K (-6.65 %)
May 09 2016	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Sell	S	120.21	10,000	1,202,121	225,707	235.7 K to 225.7 K (-4.24 %)
May 03 2016	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Sell	S	122.04	200	24,408	43,711	43.9 K to 43.7 K (-0.46 %)
May 03 2016	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Sell	S	121.45	800	97,160	43,911	44.7 K to 43.9 K (-1.79 %)
Apr 07 2016	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Sell	S	115.00	5,000	575,000	44,711	49.7 K to 44.7 K (-10.06 %)
Mar 17 2016	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Option Exercise	M	9.97	2,250	22,433	83,360
Mar 17 2016	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Option Exercise	M	9.97	6,400	63,808	85,610
Mar 17 2016	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Buy	M	9.97	2,250	22,433	78,912	76.7 K to 78.9 K (+2.93 %)
Mar 17 2016	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Sell	S	96.70	6,400	618,880	76,662	83.1 K to 76.7 K (-7.71 %)
Mar 17 2016	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	President and COO	Buy	M	9.97	6,400	63,808	83,062	76.7 K to 83.1 K (+8.35 %)
Mar 09 2016	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Sell	S	102.49	500	51,245	235,707	236.2 K to 235.7 K (-0.21 %)
Mar 09 2016	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Sell	S	101.07	5,629	568,895	236,207	241.8 K to 236.2 K (-2.33 %)
Mar 09 2016	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Option Exercise	M	21.00	6,000	126,000	22,483
Mar 09 2016	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Buy	M	21.00	6,000	126,000	125,664	119.7 K to 125.7 K (+5.01 %)
Mar 09 2016	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Sell	S	102.97	556	57,251	119,664	120.2 K to 119.7 K (-0.46 %)
Mar 09 2016	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	Chief Executive Off ...	Sell	S	102.44	10,277	1,052,776	120,220	130.5 K to 120.2 K (-7.88 %)

Page: < prev 1 2 3 4 5 6 7 8 ... 15 next >